Novo Nordisk

Novo Nordisk

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, December 3, 2025. Photo: REUTERS/Tom Little

What Novo Nordisk's weight-loss pill approval means for company, patients

The first GLP-1 pill specifically for obesity, also branded as Wegovy, is a 25-mg oral formulation of semaglutide, the active ingredient in the blockbuster injectable version

Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Photo: REUTERS/Hollie Adams/File Photo

Novo Nordisk wins US approval for weight-loss pill

Novo Nordisk, Arogga sign MoU to expand digital diabetes care

Novo Nordisk, Arogga sign MoU to expand digital diabetes care

Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Photo: REUTERS/Hollie Adams/File Photo

How Novo Nordisk misread the US market for its weight loss sensation

Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Photo: REUTERS/Hollie Adams/File Photo

Novo's trial of weight-loss drug shows improvement in fatty liver disease

Headquarter of  Novo Nordisk, a leading global healthcare company operating in the Human insulin market. Photo: Collected

Weight-loss drug forecasts jump to $150 billion as supply grows

Novo Nordisk launches once-a-week diabetes drug

Novo Nordisk launches once-a-week diabetes drug

Winnie Estrup Petersen, Ambassador, The Royal Embassy of Denmark in Bangladesh, Dr. Mihail Briciu, Managing Director of Novo Nordisk Bangladesh and Professor Dr. AK Azad Khan, President of Diabetic Association of Bangladesh (BADAS), along with others attend at the launching ceremony of world’s fastest acting insulin at a hotel in the capital on Thursday.

Novo Nordisk introduces world’s fastest acting insulin

Novo Nordisk Bangladesh plants 1,000 trees to support environment

Novo Nordisk Bangladesh plants 1,000 trees to support environment